Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01080027
What this trial is testing

Safety, Tolerability and Adherence With Rebif® New Formulation in Real Life Settings (STAR)

Who this might be right for
Multiple Sclerosis, Relapsing Remitting
Merck KGaA, Darmstadt, Germany 254
Large-scale testing (Phase 3)Active Not RecruitingNCT05123703
What this trial is testing

Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Hoffmann-La Roche 188
Not applicableStudy completedNCT03060759
What this trial is testing

Light Therapy as Treatment for Fatigue in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Massachusetts General Hospital 35
Large-scale testing (Phase 3)Study completedNCT00869986
What this trial is testing

Patients With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Eli Lilly and Company 218
Not applicableEnded earlyNCT02218879
What this trial is testing

Restoring Glutathione Synthesis With Tecfidera: An in Vivo H-MRS Single-Arm Study at 7T in Patients With RR MS

Who this might be right for
Multiple Sclerosis
Yale University 7
Large-scale testing (Phase 3)Study completedNCT00605215
What this trial is testing

BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 1,331
Not applicableUnknownNCT04042415
What this trial is testing

Calorie Restriction in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingCaloric Restriction
Federico II University 93
Testing effectiveness (Phase 2)Study completedNCT01051349
What this trial is testing

Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 410
Not applicableStudy completedNCT02017808
What this trial is testing

Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months

Who this might be right for
Multiple Sclerosis
University at Buffalo 100
Not applicableStudy completedNCT03718026
What this trial is testing

The Reliability, Validity, and Responsiveness of the Timed 360° Turn Test in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Gazi University 95
Not applicableStudy completedNCT06925022
What this trial is testing

Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: The ADVICE Protocol Study (Phase 1)

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
Universidad de Almeria 20
Testing effectiveness (Phase 2)Study completedNCT01285401
What this trial is testing

Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® Treatment

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT06800404
What this trial is testing

"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)Multiple Sclerosis
Hope Biosciences Research Foundation 10
Not applicableUnknownNCT04236544
What this trial is testing

Patient Experiences of Multiple Sclerosis (PExMS)

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingPatient Engagement+1 more
Universitätsklinikum Hamburg-Eppendorf 55
Early research (Phase 1)Ended earlyNCT01435993
What this trial is testing

Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 3
Not applicableStudy completedNCT00884481
What this trial is testing

Effects of Tysabri (BG00002) Over 12 Months on MS Related Fatigue in Participants With RRMS

Who this might be right for
Relapsing-Remitting Multiple SclerosisFatigue
Biogen 195
Testing effectiveness (Phase 2)Study completedNCT01405820
What this trial is testing

Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 290
Not applicableUnknownNCT05920018
What this trial is testing

Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Universität Münster 100
Not applicableStudy completedNCT07680738
What this trial is testing

Transcranial Direct Current Stimulation for Fatigue, Mood, and Cognition in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, MSMultiple SclerosisMultiple Sclerosis (MS) - Relapsing-remitting+5 more
Universidad de Almeria 38
Not applicableStudy completedNCT01641120
What this trial is testing

Assessing Tolerability of Avonex Intramuscular Injections

Who this might be right for
Multiple Sclerosis
Trinity Health Of New England 20
Next Page